Shoulder Innovations (SI)
NYSE Market Open
Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on products for shoulder replacement surgery. The company develops and sells implant systems and related tools used by orthopedic surgeons in shoulder arthroplasty, a procedure performed to treat conditions such as severe arthritis, traumatic injury, rotator cuff-related degeneration, and failed prior shoulder procedures.
The company’s portfolio is built around its InSet shoulder arthroplasty platform. Its products include the InSet Total Shoulder Arthroplasty system, designed for anatomic shoulder replacement, and the InSet Reverse Shoulder Arthroplasty system, used in reverse shoulder replacement procedures where joint mechanics are altered to improve function in patients with more complex shoulder pathology. Shoulder Innovations also offers the InSet Tray System to support surgical workflow and instrument organization.
In addition to implants and instruments, the company provides ProVoyance Shoulder Planning Software. Surgical planning tools are increasingly important in orthopedics because they can help physicians evaluate patient anatomy, select implants, and plan positioning before entering the operating room. For shoulder replacement, where bone shape, glenoid wear, and soft-tissue balance can vary significantly from patient to patient, planning software can be an important part of improving consistency.
Shoulder Innovations currently operates primarily in the United States and is positioned within a specialized segment of the orthopedic implant market. Unlike diversified medical device companies that sell across multiple surgical categories, Shoulder Innovations concentrates on the shoulder. This focus allows the company to align product development, surgeon education, and commercial execution around a single area of care as it seeks broader adoption of its implant systems and potential expansion beyond its existing market.
Last updated
- Market Cap
- 286.81M
- P/E
- —
- P/FCF
- —
- P/S
- 5.32
- Enterprise Value
- 290.28M
- Sector
- Health Care
- Industry
- Surgical and Medical Instruments and Apparatus
- Address
- 1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS, MI, 49507
First Republic: When Preferred Equity Goes To Zero, Part 2
Big bank earnings in spotlight following historic failures: 'Every income statement line item is in flux'.
Silvergate Capital Corporation (SI) Flat As Market Gains: What You Should Know
First Republic’s stock rallies as First Citizens deal for Silicon Valley Bank lifts banks
First Citizens' stock leaps on SVB deal, Carnival share drop after downbeat outlook, and other stocks on the move
4 Top Penny Stocks Under $5; Time To Buy Now?
Wall Street Breakfast: What Moved Markets
The Fed Is Creating A Black Swan Event Of Our Lifetime
Stock-market investors should play defense as recession looks likely, portfolio managers say
'Someone needs to tell Jerome Powell that this is not a kill-at-all-costs mission.' Cut interest rates now to prevent a full-blown banking crisis.
Coinbase’s stock is set for its longest winning streak on record
SI vs. CFR: Which Stock Is the Better Value Option?
Do Options Traders Know Something About Silvergate (SI) Stock We Don't?
Silvergate lays off president, director resigns after move to liquidate bank
Bitcoin at ‘redemption arc’ as banking pressures rise, says AllianceBernstein
First Republic Bank: When Opacity Kills Opportunity
Bank sector stress may provide a bullish case for cryptocurrencies. Here’s how
From SVB’s sudden collapse to Credit Suisse’s fallout: 8 charts show turbulence in financial markets
Signature, Silvergate collapse may create crypto liquidity issues as banks shy away from purchases
SVB's sudden collapse: 6 charts show the shock waves that ripped through global markets
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 286.81M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 290.28M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 2.16
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 5.32
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -10.36
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 5.39
- EPS
- -2.13
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -44.85M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -33.14%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -27.49%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.11
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 11.81
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 10.04
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.93
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 79.95K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 13.83
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 |
|---|---|---|---|
| Revenue | 16.71M | 14.42M | 11.76M |
| Gross profit | 12.99M | 11.06M | 8.96M |
| Operating income | -8.98M | -8.5M | -7.64M |
| EBITDA | -7.84M | -7.52M | -6.8M |
| Net income | -8.38M | -7.77M | -8.73M |
| Basic EPS | -0.41 | 2.35 | -0.64 |
| Diluted EPS | -0.41 | 2.35 | -0.64 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 |
|---|---|---|---|
| Total assets | 160.36M | 169.91M | 177.76M |
| Total liabilities | 27.34M | 29.16M | 29.93M |
| Total equity | 133.02M | 140.75M | 147.83M |
| Cash & equivalents | 11.49M | 26.87M | 54.93M |
| Current assets | 145.78M | 157.17M | 166.61M |
| Current liabilities | 12.34M | 14.2M | 15.02M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 |
|---|---|---|---|
| Operating cash flow | -12.36M | -8.78M | -8.56M |
| Investing cash flow | -3.12M | -17.28M | -72.44M |
| Financing cash flow | 101K | -2M | 108.87M |
| Change in cash | -15.38M | -28.06M | 27.88M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | 10-Q — SHOULDER INNOVATIONS, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G/A — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | DEFA14A — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | DEF 14A — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | ARS — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | 8-K — SHOULDER INNOVATIONS, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| form 4 | Form 4 — Ahearn Matthew Fraser | View Filing | |
| form 4 | Form 4 — Ahearn Matthew Fraser | View Filing | |
| form 4 | Form 4 — Ahearn Matthew Fraser | View Filing | |
| form 4 | Form 4 — Ahearn Matthew Fraser | View Filing | |
| edgar index | 8-K — SHOULDER INNOVATIONS, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| form 4 | Form 4 — BUCKMAN PAUL | View Filing | |
| form 4 | Form 4 — BUCKMAN PAUL | View Filing | |
| form 4 | Form 4 — BUCKMAN PAUL | View Filing | |
| form 4 | Form 4 — BUCKMAN PAUL | View Filing | |
| form 4 | Form 4 — BUCKMAN PAUL | View Filing | |
| form 4 | Form 4 — BUCKMAN PAUL | View Filing | |
| form 4 | Form 4 — Points Jeffrey S. | View Filing | |
| form 4 | Form 4 — Points Jeffrey S. | View Filing | |
| form 4 | Form 4 — Points Jeffrey S. | View Filing | |
| form 4 | Form 4 — Points Jeffrey S. | View Filing | |
| form 4 | Form 4 — Buchholz Richard | View Filing | |
| form 4 | Form 4 — Ball Robert Joseph | View Filing | |
| edgar index | 8-K — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | 10-K — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | S-8 — SHOULDER INNOVATIONS, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 3 — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | 8-K — SHOULDER INNOVATIONS, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| form 4 | Form 4 — Ball Robert Joseph | View Filing | |
| form 4 | Form 4 — Ball Robert Joseph | View Filing | |
| form 4 | Form 4 — Ball Robert Joseph | View Filing | |
| form 4 | Form 4 — Ball Robert Joseph | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| form 4 | Form 4 — Points Jeffrey S. | View Filing | |
| form 4 | Form 4 — Ahearn Matthew Fraser | View Filing | |
| form 4 | Form 4 — Ball Robert Joseph | View Filing | |
| form 4 | Form 4 — Blue David Lawrence | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| form 4 | Form 4 — Points Jeffrey S. | View Filing | |
| form 4 | Form 4 — Points Jeffrey S. | View Filing | |
| form 4 | Form 4 — Ahearn Matthew Fraser | View Filing | |
| form 4 | Form 4 — Ball Robert Joseph | View Filing | |
| form 4 | Form 4 — Blue David Lawrence | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | 4 — SHOULDER INNOVATIONS, INC. | View Filing | |
| form 4 | Form 4 — Ball Robert Joseph | View Filing | |
| form 4 | Form 4 — Points Jeffrey S. | View Filing | |
| form 4 | Form 4 — Ball Robert Joseph | View Filing | |
| form 4 | Form 4 — Points Jeffrey S. | View Filing | |
| form 4 | Form 4 — Points Jeffrey S. | View Filing | |
| edgar index | 8-K — SHOULDER INNOVATIONS, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — SHOULDER INNOVATIONS, INC. | View Filing | |
| edgar index | SCHEDULE 13G — SHOULDER INNOVATIONS, INC. | View Filing |